AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 ...

Eli Lilly has signed a new research deal with BigHat Biosciences to co-develop next-generation antibody therapeutics, as the ...

The therapeutic potential of targeting glucagon-like peptide-1 (GLP-1 ... In this Innovation Spotlight, Dale Wright, executive director of inflammation & systems biology and Brian Bond, vice president ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and ...

Together, these advances, along with the development of the glucagon-like peptide 1 (GLP ... understanding and the expectations for human biology,” she said. Sarah E. Hampl, MD “We really ...

Some people were on basic cell biology projects. Other people were working on different genes and glucagon was one of the projects in the lab.... It just so happened when I got there, they said ...

ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) disease, today ...

For biologists like Heiko Jansen, grizzly bears offer a fascinating opportunity to analyze seasonal metabolic changes ...